Regulation of the Innate Immune System as a Therapeutic Approach to Supporting Respiratory Function in ALS.
Ontology highlight
ABSTRACT: Amyotrophic lateral sclerosis (ALS) is a clinical diagnosis used to define a neurodegenerative process that involves progressive loss of voluntary muscle function and leads to death within 2-5 years after diagnosis, in most cases because of respiratory function failure. Respiratory vital capacity (VC) measurements are reproducible and strong predictors of survival. To understand the role of the innate immune response in progressive VC loss we evaluated ALS clinical trial and biomarker results from a 6-month phase 2 study of NP001, a regulator of innate immune function. All ALS baseline values were similar between treated and controls except for those > 65 years old who were excluded from analysis. Treated patients with plasma CRP ≥ 1.13 mg/L (high CRP) showed a 64% slower rate of VC declin
SUBMITTER: McGrath MS
PROVIDER: S-EPMC10093136 | biostudies-literature | 2023 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA